Notice names this product. MYLAN PHARMACEUTICALS’s Mycophenolate Mofetil for Injection USP is named in FDA Class II recall D-0734-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: Presence of precipitate Identifying details: Lot #: 3241653, Exp 4/30/2027. Units affected: 5688 vials. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Mycophenolate Mofetil for Injection USP, 500 mg/Vial, Single Dose Vial, 4 vials per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV, 26505 USA, Made in India, NDC 67457-386-00 (vial label) & NDC 67457-386-81 (carton label).
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
Presence of precipitate
Company / brand: MYLAN PHARMACEUTICALS
Affected product: Mycophenolate Mofetil for Injection USP
Official ID D-0734-2026 · Official record ↗
See all MYLAN PHARMACEUTICALS recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked September 7, 2026 at 6:00 AM UTC.